You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 4, April 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Eye in Bone Marrow Transplantation

II. Histopathology

Douglas A. Jabs, MD; Lawrence W. Hirst, MD; W. Richard Green, MD; Peter J. Tutschka, MD; George W. Santos, MD; William E. Beschorner, MD

Arch Ophthalmol. 1983;101(4):585-590.


Abstract

• The major histopathologic changes seen in the eyes of patients undergoing bone marrow transplantation involve the conjunctiva, cornea, choroid, and lacrimal gland. The major finding in the conjunctiva is keratinization. The major findings in the cornea are epithelial thinning and keratinization. Keratinization of the conjunctiva and cornea is associated with graft-v-host disease (GVHD) and may be either a primary manifestation of GVHD or be secondary to the "dry eye" syndrome that develops in patients with GVHD. Corneal epithelial thinning is probably secondary to the chemotherapy used in the preparative regimen. An unusual histiocytelike infiltrate is present in the choroid and appears to be associated with GVHD. In acute GVHD, lacrimal gland stasis occurs and is the probable cause of the dry eyes seen in these patients.



Author Affiliations

From the Wilmer Ophthalmological Institute (Drs Jabs, Hirst, and Green), the Department of Pathology (Drs Green and Beschorner), and the Bone Marrow Transplant Unit, Oncology Center (Drs Tutschka, Santos, and Beschorner), Johns Hopkins Medical Institutions, Baltimore. Dr Hirst is now with Bethesda Eye Institute, St Louis.


Footnotes

Accepted for publication May 3, 1982.

Read in part before the meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Fla, April 27, 1981.

Reprint requests to Bethesda Eye Institute, 3655 Vista Ave, St Louis, MO 63110 (Dr Hirst).

This investigation was supported in part by Public Health Service research grants EY 02476 (Dr Hirst) and EY 01684 (Dr Green), EM core grant EY 01765, computer core grant 2 P30 EY 01765, and grant CA 15396 from the National Cancer Institute.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Posterior segment complications of graft versus host disease after bone marrow transplantation
Strouthidis et al.
Br J Ophthalmol 2003;87:1421-1423.
FULL TEXT  

Pigmentary Irregularities and Optic Disc Edema After Heart Transplantation
Klaver et al.
Arch Ophthalmol 1995;113:1281-1285.
ABSTRACT  

The Eye in Bone Marrow Transplantation: VI. Retinal Complications
Coskuncan et al.
Arch Ophthalmol 1994;112:372-379.
ABSTRACT  

Microvasculopathy in the Ocular Fundus after Bone Marrow Transplantation
Bernauer et al.
ANN INTERN MED 1991;115:925-930.
ABSTRACT  

The Eye in Bone Marrow Transplantation: III. Conjunctival Graft-vs-Host Disease
Jabs et al.
Arch Ophthalmol 1989;107:1343-1348.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.